ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,893Medicare Part D Prescriptions Filled, Including Refills

Rank: 515 out of 3647

$457K Total Retail Price of All Prescriptions

Rank: 1267 out of 3647

767 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
27% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

1% of this provider’s 767 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

12% of this provider’s 767 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

1% of this provider’s 13,069 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$33 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
LOVASTATIN 1,072 1,036 1 21
HYDROCHLOROTHIAZIDE 830 809 2 9
LOSARTAN-HYDROCHLOROTHIAZIDE 754 690 3 48
LISINOPRIL 565 539 4 4
ATENOLOL 561 555 5 10
OMEPRAZOLE 555 535 6 3
METFORMIN HCL 533 508 7 6
RANITIDINE HCL 519 474 8 29
SIMVASTATIN 424 406 9 1
LEVOTHYROXINE SODIUM 373 372 10 5
LOSARTAN POTASSIUM 373 373 10 11
AMLODIPINE BESYLATE 361 344 12 2
VIAGRA 338 337 13 69
METOPROLOL TARTRATE 307 295 14 7
IBUPROFEN 291 276 15 55
ALPRAZOLAM 277 252 16 31
ALENDRONATE SODIUM 254 244 17 23
WARFARIN SODIUM 218 210 18 15
CARVEDILOL 179 174 19 20
HYDROCODONE-ACETAMINOPHEN 174 159 S3 20 12
GLIPIZIDE 140 140 21 41
ATORVASTATIN CALCIUM 129 125 22 13
CLOPIDOGREL 122 115 23 26
ALLOPURINOL 122 118 23 37
METOPROLOL SUCCINATE 105 100 25 18
FUROSEMIDE 104 83 26 8
NIFEDIPINE ER 99 99 27 67
ENALAPRIL MALEATE 98 95 28 35
TRAMADOL HCL 93 85 29 22
TEMAZEPAM 92 92 30 47
NAPROXEN 88 88 31 70
AMIODARONE HCL 84 81 32 211
GLYBURIDE 83 82 R 33 54
VYTORIN 81 79 34 191
FLUOXETINE HCL 76 60 35 68
ZOLPIDEM TARTRATE 76 67 35 14
PLAVIX 74 71 37 39
ACTOS 71 71 38 148
PRADAXA 63 63 39 258
INSULIN SYRINGE 62 57 40 76
DOXAZOSIN MESYLATE 62 62 40 57
NITROSTAT 62 56 40 206
SPIRONOLACTONE 59 54 43 77
GABAPENTIN 53 44 44 17
AMOXICILLIN 53 51 44 133
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 20, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.